TAG:
Roche
September 23, 2024, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXI, No. 13 – September 23, 2024 Issue
One sign of the financial turmoil associated with the market for genetic tests is the news that all seven independent directors of 23andMe’s board resigned at the same time on Sept. 18. The reason given was that these directors opposed the plan of CEO and co-founder Anne Wojcicki t…
June 10, 2024, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXI, No. 8 – June 10, 2024 Issue
Once a high-flier lab test manufacturer with a market valuation of $2 billion, Cue Health of San Diego filed for Chapter 7 bankruptcy on May 28. Analysts now say the company is valued at about $15 million. Founded in 2010, Cue Health was developing a test system that consumers could …
February 26, 2024, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXI, No. 3 – February 26, 2024 Issue
Following an investment of $1.75 million, officials at University of Maine at Augusta (UMA) opened a new lab facility this month that allows it to double the number of medical laboratory technicians it can train, from eight to 10 to as many as 20. In its coverage of the new training …
December 26, 2023, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXX, Number 18 – December 26, 2023 Issue
Is the world ready for a diagnostic service that performs a whole genome sequence of embryos conceived by in vitro fertilization? That’s the business plan announced on Dec. 5 by San Francisco-based Orchid Health. In covering this development, Science wrote, “Find the emb…
IVD and Lab Consolidation Reduces Choices for Labs
By Robert Michel | From the Volume XXX, No. 13 – September 11, 2023 Issue
CEO SUMMARY: Since the launch of The Dark Report in 1995, consolidation of hospitals, physician groups, clinical labs, pathology groups, and IVD manufacturers has been a major trend every year. Toda…
January 23, 2023, Intelligence: Late-Breaking Lab News
By Scott Wallask | From the Volume XXX No. 2 – January 23, 2023 Issue
New data from the Association of American Medical Colleges (AAMC) offers further evidence of a decreasing talent pool of pathologists in the United States. Active physicians in anatomic and clinical pathology dropped from 13,201 in 2016 to 12,180 in 2021—a 7.7% decrease, according to the AAM…
Top Public IVD Companies Report Q3/Q4 2022 Earnings
By Robert Michel | From the Volume XXIX, No. 17 – December 12, 2022 Issue
IT WAS A MIXED BAG OF THIRD QUARTER FINANCIAL RESULTS for the nation’s largest in vitro diagnostics (IVD) manufacturers, with COVID-19 testing volume a contributing factor. Fluctuating demand for SARS-CoV-2 testing proved perplexing, as some IV…
June 6, 2022 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXIX, No. 8 – June 6, 2022 Issue
Monkeypox is the latest disease showing up in the United States. That means hospital laboratories will want to be ready to diagnose monkeypox cases that show up in their emergency departments. An official from the Centers for Disease Control and Prevention (CDC) says it is exploring the possib…
April 25, 2022 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXIX, No. 6 – April 25, 2022 Issue
In a sign that awareness of medical diagnostic testing continues to grow during the SARS-CoV-2 pandemic, the Mayo Clinic announced it will invest $49 million to build a new laboratory space on its campus in Rochester, Minn. As part of the multi-year project, several clinical labs will eventual…
Pathology Firm’s Investment in AI Signals a New Trend
By Robert Michel | From the Volume XXIX, No. 3 – February 22, 2022 Issue
This is an excerpt of a 1,436-word article in the February 22, 2022 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Australian artificial intelligence (AI) company Harrison.ai got AU$129 million from multiple inve…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized
The Dark Report
1000 N West Street, Suite 1200 Wilmington, Delaware, United States, 19801
Phone: 512-264-7103
Email: info@darkreport.com
© 2025 The Dark Report. All rights reserved. Part of the LabX Media Group